Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Ankit Ganeshpurkar, Ravi Singh, Pravin Gangaram Gore, Devendra Kumar, Gopichand Gutti, Ashok Kumar & Sushil Kumar Singh. (2020) Structure-based screening and molecular dynamics simulation studies for the identification of potential acetylcholinesterase inhibitors. Molecular Simulation 46:3, pages 169-185.
Read now
Read now
Dicson Sheeja Malar, Rajamohamed Beema Shafreen, Shunmugiah Karutha Pandian & Kasi Pandima Devi. (2017) Cholinesterase inhibitory, anti-amyloidogenic and neuroprotective effect of the medicinal plant Grewia tiliaefolia – An in vitro and in silico study. Pharmaceutical Biology 55:1, pages 381-393.
Read now
Read now
Diego Muñoz-Torrero & Pelayo Camps. (2008) Huprines for Alzheimer's disease drug development. Expert Opinion on Drug Discovery 3:1, pages 65-81.
Read now
Read now
Nicolaas PLG Verhoeff. (2007) Amyloid imaging in vivo: implications for Alzheimer's disease management. Expert Opinion on Medical Diagnostics 1:3, pages 337-349.
Read now
Read now
Norman R Relkin. (2007) Beyond symptomatic therapy: a re-examination of acetylcholinesterase inhibitors in Alzheimer’s disease. Expert Review of Neurotherapeutics 7:6, pages 735-748.
Read now
Read now
Articles from other publishers (10)
Devashree N. Patil, Sushama A. Patil, Srinivas Sistla & Jyoti P. Jadhav. (2019) Comparative biophysical characterization: A screening tool for acetylcholinesterase inhibitors. PLOS ONE 14:5, pages e0215291.
Crossref
Crossref
Srabanti Jana, Ankit Ganeshpurkar & Sushil Kumar Singh. (2018)
Multiple 3D-QSAR modeling, e-pharmacophore, molecular docking, and
in vitro
study to explore novel AChE inhibitors
. RSC Advances 8:69, pages 39477-39495.
Crossref
Crossref
Hao Song, Li-Ping Huang, Yuping Li, Chao Liu, Songhua Wang, Wei Meng, Shanshan Wei, Xin-Ping Liu, Yanchun Gong & Li-Hua Yao. (2018) Neuroprotective effects of cordycepin inhibit Aβ-induced apoptosis in hippocampal neurons. NeuroToxicology 68, pages 73-80.
Crossref
Crossref
I Husain, M Akhtar, M Zainul Abdin, M Islamuddin, M Shaharyar & AK Najmi. (2017) Rosuvastatin ameliorates cognitive impairment in rats fed with high-salt and cholesterol diet via inhibiting acetylcholinesterase activity and amyloid beta peptide aggregation. Human & Experimental Toxicology 37:4, pages 399-411.
Crossref
Crossref
Kie Honjo, Sandra E. Black & Nicolaas P. L. G. Verhoeff. (2014) Alzheimer's Disease, Cerebrovascular Disease, and the β-amyloid Cascade. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 39:6, pages 712-728.
Crossref
Crossref
Masashi Shinada, Fuminori Narumi, Yuji Osada, Koji Matsumoto, Takayasu Yoshida, Kazuhiro Higuchi, Tomomi Kawasaki, Hiroyuki Tanaka & Mitsutoshi Satoh. (2012) Synthesis of phenserine analogues and evaluation of their cholinesterase inhibitory activities. Bioorganic & Medicinal Chemistry 20:16, pages 4901-4914.
Crossref
Crossref
Katy A. Chalmers, Gordon K. Wilcock, Harry V. Vinters, Elaine K. Perry, Robert Perry, Clive G. Ballard & Seth Love. (2009) Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer’s disease. Journal of Neurology 256:5, pages 717-720.
Crossref
Crossref
Victor L. Villemagne, Michelle T. Fodero-Tavoletti, Kerryn E. Pike, Roberto Cappai, Colin L. Masters & Christopher C. Rowe. (2008) The ART of Loss: Aβ Imaging in the Evaluation of Alzheimer’s Disease and other Dementias. Molecular Neurobiology 38:1, pages 1-15.
Crossref
Crossref
Hua Jiang, Jingya Zhang, Hui Zhu, Hong Li & Xuejun Zhang. (2007) Nerve Growth Factor Prevents the Apoptosis-associated Increase in Acetylcholinesterase Activity after Hydrogen Peroxide Treatment by Activating Akt. Acta Biochimica et Biophysica Sinica 39:1, pages 46-56.
Crossref
Crossref
Agneta Nordberg. (2006) Mechanisms Behind the Neuroprotective Actions of Cholinesterase Inhibitors in Alzheimer Disease. Alzheimer Disease & Associated Disorders 20:Supplement 1, pages S12-S18.
Crossref
Crossref